{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T01:19:26Z","timestamp":1794187166539,"version":"4.8.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/23\/B\/NZ5\/01477"],"award-info":[{"award-number":["2016\/23\/B\/NZ5\/01477"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.advms.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T10:22:18Z","timestamp":1706178138000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Progesterone signaling in uterine leiomyoma biology: Implications for potential targeted therapy"],"prefix":"10.1016","volume":"69","author":[{"given":"Weronika","family":"Szucio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Bernaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-7460","authenticated-orcid":false,"given":"Donata","family":"Ponikwicka-Tyszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9008-8285","authenticated-orcid":false,"given":"Gabriela","family":"Milewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Pawelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Wo\u0142czy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafis A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0030-1251477","article-title":"New directions in the epidemiology of uterine fibroids","volume":"28","author":"Laughlin","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"195","author":"Flynn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.advms.2024.01.001_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10815-012-9784-0","article-title":"Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances","volume":"29","author":"Levy","year":"2012","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ogc.2005.12.008","article-title":"Myomas and assisted reproductive technologies: when and how to act?","volume":"33","author":"Kolankaya","year":"2006","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jc.2010-1450","article-title":"Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-beta3","volume":"96","author":"Sinclair","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/aje\/kws585","article-title":"Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment","volume":"178","author":"Velez Edwards","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib7","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.fertnstert.2010.03.035","article-title":"Pregnancy-related fibroid reduction","volume":"94","author":"Laughlin","year":"2010","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.advms.2024.01.001_bib8","first-page":"1170","article-title":"Leiomyomata uteri: hormonal and molecular determinants of growth","volume":"99","author":"Blake","year":"2007","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"6053","key":"10.1016\/j.advms.2024.01.001_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.advms.2024.01.001_bib10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.08.025","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma","volume":"158","author":"Sandberg","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"10.1016\/j.advms.2024.01.001_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environ Health Perspect"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib14","first-page":"1876","article-title":"Estrogen receptor gene expression in human uterine leiomyomata","volume":"80","author":"Brandon","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.advms.2024.01.001_bib15","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/humrep\/14.11.2844","article-title":"Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy","volume":"14","author":"Nisolle","year":"1999","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9378(93)90135-6","article-title":"Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas","volume":"169","author":"Brandon","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.advms.2024.01.001_bib17","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2007-0725","article-title":"Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells","volume":"92","author":"Yin","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3\u20134","key":"10.1016\/j.advms.2024.01.001_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0897.1992.tb00746.x","article-title":"Angiogenesis in the uterus: potential regulation and relation to tumor angiogenesis","volume":"27","author":"Torry","year":"1992","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9378(89)80046-8","article-title":"Mitotic activity in uterine leiomyomas during the menstrual cycle","volume":"160","author":"Kawaguchi","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000292738","article-title":"Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis","volume":"34","author":"Lamminen","year":"1992","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/jc.2008-2093","article-title":"Progestins activate the AKT pathway in leiomyoma cells and promote survival","volume":"94","author":"Hoekstra","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.fertnstert.2020.12.011","article-title":"Mechanical stiffness augments ligand-dependent progesterone receptor B activation via MEK 1\/2 and Rho\/ROCK-dependent signaling pathways in uterine fibroid cells","volume":"116","author":"Cordeiro Mitchell","year":"2021","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/humupd\/dmn006","article-title":"Non-surgical management of uterine fibroids","volume":"14","author":"Tropeano","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib26","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker","year":"2017","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13697137.2018.1476484","article-title":"Progesterone and human cognition","volume":"21","author":"Henderson","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.advms.2024.01.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100856","article-title":"Progesterone - friend or foe?","volume":"59","author":"Sundstrom-Poromaa","year":"2020","journal-title":"Front Neuroendocrinol"},{"issue":"1\u20132","key":"10.1016\/j.advms.2024.01.001_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0039-128X(98)00104-4","article-title":"Identification of functional binding sites for progesterone in rat Leydig cell plasma membrane","volume":"64","author":"Rossato","year":"1999","journal-title":"Steroids"},{"issue":"Suppl 1","key":"10.1016\/j.advms.2024.01.001_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/15.suppl_1.14","article-title":"Progesterone, progestagens and the central nervous system","volume":"15","author":"Genazzani","year":"2000","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib31","first-page":"502","article-title":"Physiological action of progesterone in target tissues","volume":"18","author":"Graham","year":"1997","journal-title":"Endocr Rev"},{"issue":"1\u20132","key":"10.1016\/j.advms.2024.01.001_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2009.02.006","article-title":"Nongenomic activation of spermatozoa by steroid hormones: facts and fictions","volume":"308","author":"Baldi","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"10.1016\/j.advms.2024.01.001_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2174\/138955712802762194","article-title":"Sex steroid hormone effects in normal and pathologic conditions in lung physiology","volume":"12","author":"Gonzalez-Arenas","year":"2012","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.advms.2024.01.001_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06632.x","article-title":"Sex steroids, immune system, and parasitic infections: facts and hypotheses","volume":"1262","author":"Nava-Castro","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.advms.2024.01.001_bib35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2826.2009.01891.x","article-title":"Progesterone increases dopamine neurone number in differentiating mouse embryonic stem cells","volume":"21","author":"Diaz","year":"2009","journal-title":"J\u00a0Neuroendocrinol"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib36","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-14-0252","article-title":"Progesterone action in breast, uterine, and ovarian cancers","volume":"54","author":"Diep","year":"2015","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"1\u20132","key":"10.1016\/j.advms.2024.01.001_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2011.10.030","article-title":"The biology of progesterone receptor in the normal mammary gland and in breast cancer","volume":"357","author":"Obr","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006412000726","article-title":"Progesterone receptor isoforms expression pattern in human chordomas","volume":"49","author":"Camacho-Arroyo","year":"2000","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.advms.2024.01.001_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.steroids.2015.11.008","article-title":"Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells","volume":"105","author":"Pina-Medina","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.advms.2024.01.001_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108496","article-title":"New insights into progesterone actions on prolactin secretion and prolactinoma development","volume":"152","author":"Camilletti","year":"2019","journal-title":"Steroids"},{"issue":"11","key":"10.1016\/j.advms.2024.01.001_bib41","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac147","article-title":"Functions of membrane progesterone receptors (mPRs, PAQRs) in nonreproductive tissues","volume":"163","author":"Thomas","year":"2022","journal-title":"Endocrinology"},{"issue":"5\u20137","key":"10.1016\/j.advms.2024.01.001_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.steroids.2005.02.012","article-title":"Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators","volume":"70","author":"Faivre","year":"2005","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrm1009","article-title":"Nongenomic actions of steroid hormones","volume":"4","author":"Losel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bpobgyn.2004.01.006","article-title":"Steroid receptor action","volume":"18","author":"Brosens","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(01)01189-X","article-title":"Progesterone receptor isoform A inhibits isoform B-mediated transactivation in human amnion","volume":"427","author":"Pieber","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib46","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/MCB.15.4.1847","article-title":"Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors","volume":"15","author":"Kraus","year":"1995","journal-title":"Mol Cell Biol"},{"issue":"18","key":"10.1016\/j.advms.2024.01.001_bib47","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","article-title":"Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities","volume":"9","author":"Lydon","year":"1995","journal-title":"Genes Dev"},{"issue":"17","key":"10.1016\/j.advms.2024.01.001_bib48","doi-asserted-by":"crossref","first-page":"9744","DOI":"10.1073\/pnas.1732707100","article-title":"Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform","volume":"100","author":"Mulac-Jericevic","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.advms.2024.01.001_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0303-7207(01)00465-8","article-title":"Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice","volume":"179","author":"Conneely","year":"2001","journal-title":"Mol Cell Endocrinol"},{"issue":"5485","key":"10.1016\/j.advms.2024.01.001_bib50","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1126\/science.289.5485.1751","article-title":"Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform","volume":"289","author":"Mulac-Jericevic","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib51","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1210\/endo-126-6-2882","article-title":"Developmental regulation of murine mammary progesterone receptor gene expression","volume":"126","author":"Shyamala","year":"1990","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/dbio.1999.9329","article-title":"Impaired mammary gland development in Cyl-1(-\/-) mice during pregnancy and lactation is epithelial cell autonomous","volume":"212","author":"Fantl","year":"1999","journal-title":"Dev Biol"},{"issue":"10\u201313","key":"10.1016\/j.advms.2024.01.001_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0039-128X(03)00129-6","article-title":"Progesterone receptor transcription and non-transcription signaling mechanisms","volume":"68","author":"Leonhardt","year":"2003","journal-title":"Steroids"},{"issue":"7338","key":"10.1016\/j.advms.2024.01.001_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature09767","article-title":"Progesterone activates the principal Ca2+ channel of human sperm","volume":"471","author":"Lishko","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jcb.20180","article-title":"Regulation of cell signalling cascades by steroid hormones","volume":"93","author":"Cheskis","year":"2004","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.advms.2024.01.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106082","article-title":"Molecular modeling, mutational analysis and steroid specificity of the ligand binding pocket of mPRalpha (PAQR7): shared ligand binding with AdipoR1 and its structural basis","volume":"219","author":"Kelder","year":"2022","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"11","key":"10.1016\/j.advms.2024.01.001_bib57","article-title":"Membrane progesterone receptors (mPRs, PAQRs): review of structural and signaling characteristics","volume":"11","author":"Thomas","year":"2022","journal-title":"Cells-Basel."},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2021.100529","article-title":"PAQR7: an intermediary mediating nongenomic progesterone action in female reproductive tissue","volume":"21","author":"Wang","year":"2021","journal-title":"Reprod Biol"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib59","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1073\/pnas.0436133100","article-title":"Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor","volume":"100","author":"Zhu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1095\/biolreprod.105.049924","article-title":"Multiplicity of progesterone's actions and receptors in the mammalian ovary","volume":"75","author":"Peluso","year":"2006","journal-title":"Biol Reprod"},{"issue":"7","key":"10.1016\/j.advms.2024.01.001_bib61","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/me.2005-0243","article-title":"Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term","volume":"20","author":"Karteris","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"9","key":"10.1016\/j.advms.2024.01.001_bib62","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1210\/en.2006-0002","article-title":"Cloning and characterization of an ovine intracellular seven transmembrane receptor for progesterone that mediates calcium mobilization","volume":"147","author":"Ashley","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.repbio.2013.09.001","article-title":"The putative roles of nuclear and membrane-bound progesterone receptors in the female reproductive tract","volume":"13","author":"Kowalik","year":"2013","journal-title":"Reprod Biol"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1095\/biolreprod.114.122986","article-title":"Progesterone receptor membrane component-1 (PGRMC1) and PGRMC-2 interact to suppress entry into the cell cycle in spontaneously immortalized rat granulosa cells","volume":"91","author":"Peluso","year":"2014","journal-title":"Biol Reprod"},{"issue":"9\u201310","key":"10.1016\/j.advms.2024.01.001_bib65","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.steroids.2007.12.017","article-title":"Progesterone receptor membrane component 1--many tasks for a versatile protein","volume":"73","author":"Losel","year":"2008","journal-title":"Steroids"},{"issue":"12","key":"10.1016\/j.advms.2024.01.001_bib66","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1210\/jc.2006-1128","article-title":"Progesterone regulation of human granulosa\/luteal cell viability by an RU486-independent mechanism","volume":"91","author":"Engmann","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pharmthera.2008.09.006","article-title":"PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding","volume":"121","author":"Rohe","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.advms.2024.01.001_bib68","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ebiom.2019.08.035","article-title":"Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression","volume":"47","author":"Ponikwicka-Tyszko","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib69","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.steroids.2012.12.002","article-title":"PGRMC2, a yet uncharacterized protein with potential as tumor suppressor, migration inhibitor, and regulator of cytochrome P450 enzyme activity","volume":"78","author":"Wendler","year":"2013","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib70","first-page":"640","article-title":"Conditional ablation of progesterone receptor membrane component 2 causes female premature reproductive senescence","volume":"158","author":"Clark","year":"2017","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.advms.2024.01.001_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2010.09.006","article-title":"Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications","volume":"76","author":"Dressing","year":"2011","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12672-012-0106-x","article-title":"Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors","volume":"3","author":"Dressing","year":"2012","journal-title":"Horm Cancer"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2015.03.030","article-title":"Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells","volume":"362","author":"Vares","year":"2015","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib74","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/bcr2588","article-title":"Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway","volume":"12","author":"Zuo","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.advms.2024.01.001_bib75","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac078","article-title":"Pleiotropic actions of PGRMC proteins in cancer","volume":"163","author":"Pru","year":"2022","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib76","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","article-title":"Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder","volume":"28","author":"Chegini","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2005.12.001","article-title":"Steroid hormones and leiomyomas","volume":"33","author":"Marsh","year":"2006","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib79","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01606522","article-title":"Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy","volume":"419","author":"Kawaguchi","year":"1991","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib80","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","article-title":"Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics","volume":"82","author":"Carney","year":"2002","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib81","first-page":"540","article-title":"Differential regulatory effect of progesterone on the proliferation and apoptosis of uterine leiomyoma tissue explants and primary leiomyoma cell cultures","volume":"25","author":"Voronin","year":"2021","journal-title":"JBRA Assist Reprod"},{"issue":"12","key":"10.1016\/j.advms.2024.01.001_bib82","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jcem-9-12-1273","article-title":"The progesterone therapy of human uterine leiomyomas","volume":"9","author":"Segaloff","year":"1949","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004347-198506000-00001","article-title":"The effect of progestins on the mitotic activity of uterine fibromyomas","volume":"4","author":"Tiltman","year":"1985","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib84","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.maturitas.2014.04.011","article-title":"Management of leiomyomas in perimenopausal women","volume":"78","author":"Ciarmela","year":"2014","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib85","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12905-022-01924-6","article-title":"Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma","volume":"22","author":"Tanioka","year":"2022","journal-title":"BMC Wom Health"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib86","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib87","first-page":"2192","article-title":"Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma","volume":"83","author":"Shimomura","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib88","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib89","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib90","first-page":"293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone","volume":"82","author":"Matsuo","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib91","first-page":"2275","article-title":"Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone","volume":"86","author":"Kurachi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.advms.2024.01.001_bib92","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.advms.2024.01.001_bib93","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41388-018-0612-6","article-title":"Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.advms.2024.01.001_bib94","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/en.2005-0016","article-title":"Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor","volume":"146","author":"Jeong","year":"2005","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/dbio.2002.0645","article-title":"Indian hedgehog as a progesterone-responsive factor mediating epithelial-mesenchymal interactions in the mouse uterus","volume":"245","author":"Matsumoto","year":"2002","journal-title":"Dev Biol"},{"issue":"6675","key":"10.1016\/j.advms.2024.01.001_bib96","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/33176","article-title":"Inhibition of oxytocin receptor function by direct binding of progesterone","volume":"392","author":"Grazzini","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1095\/biolreprod.103.020180","article-title":"Nongenomic inhibition of oxytocin binding by progesterone in the ovine uterus","volume":"70","author":"Dunlap","year":"2004","journal-title":"Biol Reprod"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib98","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr Rev"},{"issue":"8 Suppl 1","key":"10.1016\/j.advms.2024.01.001_bib99","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IJG.0000000000000108","article-title":"Biology of the extracellular matrix: an overview","volume":"23","author":"Yue","year":"2014","journal-title":"J\u00a0Glaucoma"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065778","article-title":"Update on the role and regulatory mechanism of extracellular matrix in the pathogenesis of uterine fibroids","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib101","first-page":"602","article-title":"[Histological and biochemical studies of collagen in human uterine leiomyomas]","volume":"60","author":"Fujita","year":"1985","journal-title":"Hokkaido Igaku Zasshi"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib102","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"28","author":"Malik","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib103","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/2049-1891-5-52","article-title":"Transforming growth factor beta signaling in uterine development and function","volume":"5","author":"Li","year":"2014","journal-title":"J\u00a0Anim Sci Biotechnol"},{"issue":"11","key":"10.1016\/j.advms.2024.01.001_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112435","article-title":"Role of transforming growth factor beta in uterine fibroid biology","volume":"18","author":"Ciebiera","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum Reprod Update"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib106","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.fertnstert.2009.01.081","article-title":"Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3","volume":"93","author":"Joseph","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.advms.2024.01.001_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"11","key":"10.1016\/j.advms.2024.01.001_bib108","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/molehr\/3.11.1005","article-title":"Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression","volume":"3","author":"Dou","year":"1997","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib109","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsgi.2003.09.004","article-title":"Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma","volume":"11","author":"Bodner-Adler","year":"2004","journal-title":"J\u00a0Soc Gynecol Invest"},{"issue":"9","key":"10.1016\/j.advms.2024.01.001_bib110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/09513590701557416","article-title":"Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium","volume":"23","author":"Bogusiewicz","year":"2007","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib111","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","article-title":"Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer","volume":"23","author":"Morikawa","year":"2008","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.advms.2024.01.001_bib112","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","article-title":"Collagens--structure, function, and biosynthesis","volume":"55","author":"Gelse","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib113","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib114","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.fertnstert.2010.12.028","article-title":"Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle","volume":"95","author":"Iwahashi","year":"2011","journal-title":"Fertil Steril"},{"issue":"Suppl 3","key":"10.1016\/j.advms.2024.01.001_bib115","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.fertnstert.2004.04.030","article-title":"Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium","volume":"82","author":"Leppert","year":"2004","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib116","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib117","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1933719115607994","article-title":"Proteoglycans in leiomyoma and normal myometrium: abundance, steroid hormone control, and implications for pathophysiology","volume":"23","author":"Barker","year":"2016","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.advms.2024.01.001_bib118","first-page":"129","article-title":"Tumor angiogenesis and angiogenesis factors","volume":"26","author":"Simpson","year":"1983","journal-title":"Microvasc Res"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib119","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1677\/joe.0.1110357","article-title":"Angiogenesis in reproductive tissues","volume":"111","author":"Findlay","year":"1986","journal-title":"J\u00a0Endocrinol"},{"issue":"7","key":"10.1016\/j.advms.2024.01.001_bib120","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/15.7.1469","article-title":"An immunohistochemical analysis of fibroid vasculature","volume":"15","author":"Casey","year":"2000","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib121","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/humrep\/deg213","article-title":"Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy","volume":"18","author":"Walocha","year":"2003","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib122","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humupd\/dmt042","article-title":"The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy","volume":"20","author":"Tal","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib123","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dep437","article-title":"Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy","volume":"25","author":"Khan","year":"2010","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.advms.2024.01.001_bib124","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum Reprod"},{"issue":"8 Suppl","key":"10.1016\/j.advms.2024.01.001_bib125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719107311464","article-title":"Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells","volume":"14","author":"Ohara","year":"2007","journal-title":"Reprod Sci"},{"issue":"Suppl 5","key":"10.1016\/j.advms.2024.01.001_bib126","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1289\/ehp.00108s5795","article-title":"Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium","volume":"108","author":"Dixon","year":"2000","journal-title":"Environ Health Perspect"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib127","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1095\/biolreprod53.3.636","article-title":"Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium","volume":"53","author":"Mangrulkar","year":"1995","journal-title":"Biol Reprod"},{"issue":"7","key":"10.1016\/j.advms.2024.01.001_bib128","first-page":"2808","article-title":"Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density","volume":"6","author":"Hague","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib129","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/cs1010691","article-title":"Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium","volume":"101","author":"Gentry","year":"2001","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib130","first-page":"1853","article-title":"Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata","volume":"80","author":"Harrison-Woolrych","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.advms.2024.01.001_bib131","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/emmm.201302618","article-title":"VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy","volume":"5","author":"Kim","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib132","first-page":"1707","article-title":"Aberrant expression of Cyr61, a member of the CCN (CTGF\/Cyr61\/Cef10\/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas","volume":"86","author":"Sampath","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib133","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1933719112459233","article-title":"Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles","volume":"20","author":"Tsiligiannis","year":"2013","journal-title":"Reprod Sci"},{"issue":"7","key":"10.1016\/j.advms.2024.01.001_bib134","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/humrep\/del035","article-title":"A\u00a0novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells","volume":"21","author":"Wang","year":"2006","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.advms.2024.01.001_bib135","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-07-6339","article-title":"Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia","volume":"68","author":"Mayer","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.advms.2024.01.001_bib136","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/978-1-4419-1241-1_58","article-title":"HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas","volume":"662","author":"Mayer","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.advms.2024.01.001_bib137","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: good and evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib138","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","article-title":"Clinical utility of progesterone receptor modulators and their effect on the endometrium","volume":"21","author":"Spitz","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib139","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","article-title":"In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment","volume":"104","author":"Courtoy","year":"2015","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1933719117728802","article-title":"Ulipristal acetate and extracellular matrix production in human leiomyomas in vivo: a laboratory analysis of a randomized placebo controlled trial","volume":"25","author":"Cox","year":"2018","journal-title":"Reprod Sci"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib141","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/humupd\/dmaa009","article-title":"Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure","volume":"26","author":"Reis","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.advms.2024.01.001_bib142","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib143","article-title":"Markers of cellular proliferation, apoptosis, estrogen\/progesterone receptor expression and fibrosis in selective progesterone receptor modulator (ulipristal acetate)-treated uterine fibroids","volume":"10","author":"Szydlowska","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib144","first-page":"1857","article-title":"Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix","volume":"42","author":"Shin","year":"2018","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.advms.2024.01.001_bib145","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.fertnstert.2018.12.026","article-title":"Ulipristal acetate decreases active TGF-beta3 and its canonical signaling in uterine leiomyoma via two novel mechanisms","volume":"111","author":"Lewis","year":"2019","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.advms.2024.01.001_bib146","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.rbmo.2018.04.050","article-title":"Gene expression changes in uterine myomas in response to ulipristal acetate treatment","volume":"37","author":"Courtoy","year":"2018","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"10.1016\/j.advms.2024.01.001_bib147","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/hmg\/ddac217","article-title":"Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate","volume":"32","author":"Kolterud","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.advms.2024.01.001_bib148","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/03602532.2021.1917599","article-title":"Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity","volume":"53","author":"Dinis-Oliveira","year":"2021","journal-title":"Drug Metab Rev"},{"issue":"5","key":"10.1016\/j.advms.2024.01.001_bib149","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/humrep\/deac009","article-title":"Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids","volume":"37","author":"Middelkoop","year":"2022","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.advms.2024.01.001_bib150","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa2008283","article-title":"Treatment of uterine fibroid symptoms with relugolix combination therapy","volume":"384","author":"Al-Hendy","year":"2021","journal-title":"N\u00a0Engl J Med"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112624000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112624000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:08Z","timestamp":1761824648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112624000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1896112624000014"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2024.01.001","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progesterone signaling in uterine leiomyoma biology: Implications for potential targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Medical University of Bialystok.","name":"copyright","label":"Copyright"}]}}